tirzepatide to retatrutide vs Tirzepatide: Triple vs Dual Agonist How To Switch From Tirzepatide

Maia Anderson Maia Anderson is a senior reporter at Healthcare Brew, where she focuses on pharma developments like GLP-1s and psychedelic medicine, pharmacies, and women's health.

This single equipment choice, often at minimal additional cost per syringe, meaningfully extends how far your medication supply goes

Although 11 studies (including nearly 6,000 patients) had a history of suicide attempt/depression as exclusion criteria for enrollment, removal of these studies did not affect the overall findings of the meta-analysis

Future FDA-approved access: If approval happens, the pricing model will likely shift again toward branded pricing, insurance rules, copays, prior authorization, and retail or specialty pharmacy dispensing

Tuesday: The Guidance Shock On February 3rd, Novo Nordisk pre-released its 2026 outlook and it was ugly

Some people claim that the prices increase over time, making them an expensive option